DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 52 filers reported holding DERMA SCIENCES INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $19,512,000 | +11.3% | 3,752,390 | 0.0% | 0.19% | +20.1% |
Q3 2016 | $17,524,000 | +18.5% | 3,752,390 | 0.0% | 0.16% | +2.6% |
Q2 2016 | $14,784,000 | +27.1% | 3,752,390 | 0.0% | 0.16% | +26.0% |
Q1 2016 | $11,632,000 | -32.2% | 3,752,390 | 0.0% | 0.12% | -13.4% |
Q4 2015 | $17,148,000 | +5.3% | 3,752,390 | +8.5% | 0.14% | -5.3% |
Q3 2015 | $16,286,000 | -34.2% | 3,457,841 | 0.0% | 0.15% | -30.9% |
Q2 2015 | $24,758,000 | -15.5% | 3,457,841 | 0.0% | 0.22% | -11.1% |
Q1 2015 | $29,288,000 | -11.1% | 3,457,841 | -2.2% | 0.24% | -27.4% |
Q4 2014 | $32,931,000 | +11.8% | 3,537,137 | 0.0% | 0.34% | -9.4% |
Q3 2014 | $29,464,000 | -27.9% | 3,537,137 | 0.0% | 0.37% | -25.9% |
Q2 2014 | $40,889,000 | -8.8% | 3,537,137 | 0.0% | 0.50% | -12.1% |
Q1 2014 | $44,851,000 | +62.0% | 3,537,137 | +38.2% | 0.57% | +46.2% |
Q4 2013 | $27,687,000 | -12.6% | 2,558,857 | 0.0% | 0.39% | -13.3% |
Q3 2013 | $31,679,000 | +74.6% | 2,558,857 | +88.3% | 0.45% | +25.3% |
Q2 2013 | $18,141,000 | – | 1,358,857 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 1,185,632 | $11,038,000 | 5.31% |
DAFNA Capital Management LLC | 384,794 | $3,582,000 | 2.83% |
Consonance Capital Management LP | 1,632,627 | $15,200,000 | 1.96% |
Broadfin Capital, LLC | 3,713,754 | $34,576,000 | 1.50% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 265,946 | $2,476,000 | 0.85% |
Senvest Management, LLC | 1,151,926 | $10,724,000 | 0.76% |
HealthCor Management, L.P. | 920,000 | $8,565,000 | 0.48% |
J. Goldman & Co LP | 365,000 | $3,398,000 | 0.40% |
Baker Brothers Advisors | 3,537,137 | $32,931,000 | 0.34% |
Perceptive Advisors | 313,583 | $2,919,000 | 0.24% |